Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Perturbed Microbiota/Immune Homeostasis in Multiple Sclerosis.
Sterlin D, Larsen M, Fadlallah J, Parizot C, Vignes M, Autaa G, Dorgham K, Juste C, Lepage P, Aboab J, Vicart S, Maillart E, Gout O, Lubetzki C, Deschamps R, Papeix C, Gorochov G. Sterlin D, et al. Among authors: papeix c. Neurol Neuroimmunol Neuroinflamm. 2021 May 11;8(4):e997. doi: 10.1212/NXI.0000000000000997. Print 2021 Jul. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33975914 Free PMC article.
Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
Lebrun C, Bensa C, Debouverie M, Wiertlevski S, Brassat D, de Seze J, Rumbach L, Pelletier J, Labauge P, Brochet B, Tourbah A, Clavelou P; Club Francophone de la Sclérose en Plaques. Lebrun C, et al. Arch Neurol. 2009 Jul;66(7):841-6. doi: 10.1001/archneurol.2009.119. Arch Neurol. 2009. PMID: 19597085
[Monoclonal antibodies in multiple sclerosis].
Papeix C, Lubetzki C. Papeix C, et al. Med Sci (Paris). 2009 Dec;25(12):1113-5. doi: 10.1051/medsci/200925121113. Med Sci (Paris). 2009. PMID: 20035688 Free article. Review. French.
[Current treatment for multiple sclerosis].
Papeix C, Lubetzki C, Lyon-Caen O. Papeix C, et al. Presse Med. 2010 Mar;39(3):381-8. doi: 10.1016/j.lpm.2009.05.021. Epub 2010 Jan 27. Presse Med. 2010. PMID: 20106633 French.
[New and emerging treatments for multiple sclerosis].
Louapre C, Maillart É, Papeix C, Lubetzki C. Louapre C, et al. Among authors: papeix c. Med Sci (Paris). 2013 Dec;29(12):1105-10. doi: 10.1051/medsci/20132912013. Epub 2013 Dec 20. Med Sci (Paris). 2013. PMID: 24356140 Free article. Review. French.
Switching from natalizumab to fingolimod in multiple sclerosis: a French prospective study.
Cohen M, Maillart E, Tourbah A, De Sèze J, Vukusic S, Brassat D, Anne O, Wiertlewski S, Camu W, Courtois S, Ruet A, Debouverie M, Le Page E, Casez O, Heinzlef O, Stankoff B, Bourre B, Castelnovo G, Rico A, Berger E, Camdessanche JP, Defer G, Clavelou P, Al Khedr A, Zephir H, Fromont A, Papeix C, Brochet B, Pelletier J, Lebrun C; Club Francophone de la Sclérose en Plaques Investigators. Cohen M, et al. Among authors: papeix c. JAMA Neurol. 2014 Apr;71(4):436-41. doi: 10.1001/jamaneurol.2013.6240. JAMA Neurol. 2014. PMID: 24566807 Clinical Trial.
170 results